Dr William P Brooks, MD | |
3741 Houston Ave, Macon, GA 31206-2415 | |
(478) 781-2992 | |
(478) 781-7152 |
Full Name | Dr William P Brooks |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 57 Years |
Location | 3741 Houston Ave, Macon, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952361123 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 11935 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medical Center, Navicent Health (the) | Macon, GA | Hospital |
Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
First Choice Primary Care, Inc. | 6103907316 | 9 |
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
Older men with high-risk prostate cancer frequently are offered fewer - and less effective - choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
President Barack Obama will soon nominate Dr. Donald M. Berwick to "run Medicare and Medicaid, the programs that serve nearly one-third of all Americans, administration officials said Saturday," The New York Times reports.
› Verified 8 days ago
Entity Name | First Choice Primary Care, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336332857 PECOS PAC ID: 6103907316 Enrollment ID: O20101006000825 |
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
Older men with high-risk prostate cancer frequently are offered fewer - and less effective - choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
President Barack Obama will soon nominate Dr. Donald M. Berwick to "run Medicare and Medicaid, the programs that serve nearly one-third of all Americans, administration officials said Saturday," The New York Times reports.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William P Brooks, MD 3741 Houston Ave, Macon, GA 31206-2415 Ph: (478) 781-2992 | Dr William P Brooks, MD 3741 Houston Ave, Macon, GA 31206-2415 Ph: (478) 781-2992 |
News Archive
Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.
Older men with high-risk prostate cancer frequently are offered fewer - and less effective - choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
President Barack Obama will soon nominate Dr. Donald M. Berwick to "run Medicare and Medicaid, the programs that serve nearly one-third of all Americans, administration officials said Saturday," The New York Times reports.
› Verified 8 days ago
Dr. Shuichi Nakai, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3780 Eisenhower Pkwy, Macon, GA 31206 Phone: 478-633-5550 Fax: 478-633-7287 | |
Sam G Amporful, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 721 Riverside Drive Lane, Macon, GA 31201 Phone: 478-259-3439 Fax: 478-254-2733 | |
Mrs. Stephanie Faye Bennett, Family Medicine Medicare: Medicare Enrolled Practice Location: 101 Gateway Drive, Macon, GA 31210 Phone: 478-210-1670 | |
Dr. Robert C Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Riverside Dr Ste B300, Macon, GA 31210 Phone: 478-405-5252 Fax: 478-477-8411 | |
Alice Rose House, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 College St, Suite A, Macon, GA 31207 Phone: 478-301-4111 Fax: 478-301-5812 | |
Dione Duc, Family Medicine Medicare: Medicare Enrolled Practice Location: 777 Hemlock St # 104, Macon, GA 31201 Phone: 478-633-7550 Fax: 478-633-3235 | |
Collier Branan Gladin Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 N Crest Blvd, Macon, GA 31210 Phone: 478-757-8335 Fax: 478-757-8353 |